EMA’s Approach to Process Validation Moves Closer to U.S. FDA’s Stance
While drugmakers should prepare for the most far-reaching approach to process validation, the U.S. Food and Drug Administration’s (FDA) lifecycle approach, they should also be aware of upcoming guidance from the European Medicines Agency (EMA), an expert says.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.